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SUMMARY
Aims: To evaluate the acute effects of the mitochondrial complex I inhibitor rotenone on
rat hippocampal synaptic plasticity. Methods: Electrophysiological field potential record-
ings were used to measure basal synaptic transmission and synaptic plasticity in rat coronal
hippocampal slices. Synaptic long-term potentiation (LTP) was induced by high-frequency
stimulation (100 Hz, 1 second × 3 at an interval of 20 seconds). In addition, mitochon-
drial complex I function was measured using MitoSOX imaging in mitochondrial prepara-
tions. Results: Acute exposure of hippocampal slices to 50 nM rotenone for 1 h did not
alter basal CA3–CA1 synaptic transmission though 500 nM rotenone significantly reduced
basal synaptic transmission. However, 50 nM rotenone significantly impaired LTP and this
rotenone’s effect was prevented by co-application of rotenone plus the ketones acetoacetate
and β-hydroxybutyrate (1 mM each). Finally, we measured mitochondrial function using
MitoSOX imaging in mitochondrial preparations and found that 50 nM rotenone partially
reduced mitochondrial function whereas 500 nM rotenone completely eliminated mito-
chondrial function. Conclusions: Our findings suggest that mitochondrial activity driven
by complex I is a sensitive modulator of synaptic plasticity in the hippocampus. Acute ex-
posure of the hippocampus to rotenone eliminates complex I function and in turn impairs
LTP.
Introduction
Mitochondrial dysfunction is a common finding in neurodegen-
erative diseases. In particular, impairment of respiratory chain
complex I has been implicated in the pathogenesis of Parkinson’s
disease (PD) [1, 2]. Rotenone, a natural complex I inhibitor ex-
tracted from the roots of lonchocarpus species, induces oxidative
stress, impairs mitochondrial energy production and causes a PD-
like syndrome in rodents [3]. Dopaminergic neurons in the sub-
stantia nigra (SN) gradually degenerate in PD, leading to a variety
of motor manifestations [3, 4]. PD patients also exhibit nonmo-
tor abnormalities, including cognitive deficits, but the underlying
mechanisms are largely unknown. The hippocampus is an impor-
tant structure for several forms of learning and memory and is
commonly affected in neurological diseases that impair cognition
[5–7].
Previous studies have reported that micromolar concentrations
of rotenone induce neuronal degeneration in primary neuronal
and hippocampal slice cultures [8, 9] and disrupt basal synap-
tic transmission in acute hippocampal slices [10, 11]. It has been
reported that the dendritic mitochondria of hippocampal neu-
rons play an important role in the morphogenesis and plastic-
ity of spines and synapses [12]. However, the effects of acute
impaired mitochondrial function by rotenone on hippocampal
synaptic plasticity– a cellular correlate of learning and memory–
have not been well-investigated. This gap in knowledge might
preclude understanding of the mechanisms underlying cognitive
deficits in PD. In the present study, we ascertained the effects
of acute exposure to rotenone on hippocampal synaptic activi-
ties, including basal synaptic transmission, paired-pulse facilita-
tion (PPF) and long-term potentiation (LTP). We found that a
low concentration of rotenone (50 nM), which was enough to in-
hibit complex I-driven mitochondrial respiration without affect-
ing basal synaptic transmission, significantly altered short- and
long-term synaptic plasticity in the CA1 region of rat hippocampal
slices. Complex I involvement was confirmed by pretreatment of
hippocampal slices with the ketones acetoacetate and β-
hydroxybutyrate (1 mM each), a combination previously shown
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to prevent calcium-mediated disruption of complex I activity [11].
Ketones are produced by the liver when caloric intake is restricted
and are used by mitochondria to satisfy cellular energy require-
ments in the absence of glucose. Our results revealed that ke-




Hippocampal slices were prepared from 4–6-week-old Wistar rats
as previously described [13–16]. Brains were rapidly removed un-
der deep isoflurane anesthesia and bathed in cold (4◦C) artificial
cerebrospinal fluid (ACSF) containing (in mM): NaCl 119; KCl 2.5;
NaHCO3 26; MgSO3 1.3; NaH2PO4 1.0; CaCl2 2.5 and glucose 11;
pH 7.4. The ACSF was continuously bubbled with 95% O2–5%
CO2 (carbogen). Coronal sections (400 μm) containing the dor-
sal hippocampus were cut with a vibratome (Vibroslice 725 M,
WPI, Sarasota, FL, USA) and transferred to a holding chamber and
incubated at room temperature (21 ± 1◦C) for at least 60 min
before recording. Slices were then transferred to a liquid-air inter-
face chamber (Fine Science Tools, Inc., Foster City, CA, USA) and
suspended on a nylon net at the liquid-air interface in a bath of
continuously dripping oxygenated ACSF (2–2.5 mL/min). Humid-
ified carbogen was passed along the upper surface of the slice, and
bath temperature was set at 30 ± 1◦C.
Electrophysiological Recordings
Standard extracellular field potential recordings were performed
in the stratum radiatum of the hippocampal CA1 region using
borosilicate glass micropipettes pulled to a tip diameter of about 1
μm and filled with 2M NaCl [13, 15]. Evoked field excitatory post-
synaptic potentials (fEPSPs) were recorded using an Axoclamp-2B
amplifier (Axon Instruments Inc., Union City, CA, USA). Schaffer
collaterals were stimulated with a custom bipolar platinum wire
electrode (diameter 0.003”) connected to an isolated pulse stimu-
lator (Model 2100, AM Systems, Carlsborg, WA, USA). Stimulus
intensity was determined using input–output response curves and
was set at 50% of the maximal response. LTP was induced by high-
frequency tetanic stimulations (100 Hz, 1 second × 3 at intervals of
20 seconds) of Schaffer collaterals following a stable 20-min base-
line. fEPSPs were subsequently recorded for an additional 60 min
at 0.03 Hz.
Mitochondrial Isolation and Measurement of
Mitochondrial Respiration
All experimental protocols were approved by the Institutional An-
imal Care and Use Committee at the Barrow Neurological In-
stitute (A3519–01). Brains from 4–6-week-old Wistar rats were
rapidly removed under deep isoflurane anesthesia and bathed in
cold (4◦C) isolation buffer (in mM: sucrose 320; EDTA 1; Tris-HCl
10; pH adjusted to 7.4 with KOH). The cortical and hippocampal
regions were isolated and manually homogenized with a dounce
tissue grinder (BellCo, Vineland, NJ, USA). The homogenized tis-
sues were initially centrifuged at 1000 rpm for 10 min (4◦C) to
remove large cellular debris. The supernatant was then recovered
and centrifuged at 14,000 rpm (4◦C) to isolate the mitochondrial
fraction. The supernatant was discarded and the pellet was dis-
solved in respiration buffer (in mM unless otherwise stated: EDTA
0.5; MgCl2 3; KCl 40; KH2PO4 10; HEPES 20; sucrose 110; BSA
1 g/L; pH adjusted to 7.4 with KOH). Mitochondrial respiration
was measured with the Oxygen Biosensory System (BD Bio-
sciences, San Jose, CA, USA) at room temperature. The Oxygen
Biosensory System consists of 96-well plates coated with an oxy-
gen sensitive fluorescent indicator. Higher fluorescence reflects in-
creased oxygen consumption and, therefore, enhanced mitochon-
drial respiration. We added 0.5 mg of protein to each well and
triggered complex I-dependent state III respiration with 5 mM glu-
tamate, 5 mM malate and 1 mM ADP (all in respiration buffer at
pH 7.4).
Data Analysis and Drugs
Data were acquired through an Axon Digidata 1322 (Axon In-
struments) interface board set to a sampling frequency of 10 kHz
and controlled with pClamp 9.2 (Axon Instruments), filtered in
Clampfit 9.0 (Axon Instruments) using an 8-pole Bessel filter and
a 1-kHz low-pass filter, and stored on hard media for subsequent
off-line analysis. Statistical comparisons using Student’s t-test (in-
dependent or paired) or analysis of variance were performed
with Origin 5.0 (Microcal Software Inc., Northampton, MA, USA).
P values less than 0.05 were considered to be statistically signifi-
cant. Drugs used in the present study included rotenone, lithium
acetoacetate and DL-β-hydroxybutyric acid sodium salt that were
purchased from Sigma–Aldrich (St. Louis, MO, USA). Rotenone
was dissolved to 100 μM stock solution using DMSO and was di-
luted to 50 nM concentration using incubation solution before ex-
periment. All drugs were applied to slices via a bath-application
system.
Results
Effects of Rotenone on Basal Synaptic
Transmission in Hippocampal Slices
Repetitive stimulation (5–10 V, 100 μs, 0.03 Hz) of Schaffer col-
laterals induced typical evoked fEPSPs in the hippocampal CA1
region, which were stable for 1 h (Figure 1A). Bath-perfusion of
rotenone at 50 nM (Figure 1B) did not significantly affect basal
synaptic transmission, but 500 nM rotenone significantly reduced
the slope of fEPSPs (Figure 1C, n = 6). Statistical analyses showed
that the normalized fEPSP slope was 1.02 ± 0.02 after rotenone
exposure for 1–10 min and 0.64 ± 0.02 after exposure between
70–80 min (Figure 1D, P < 0.01). These results suggest that acute
exposure to rotenone impairs hippocampal synaptic transmission
dependent upon concentration and exposure period.
Effects of Rotenone on LTP in Hippocampal Slices
To assess the effects of rotenone on LTP, we measured high-
frequency stimuli (100 Hz, 1 second × 3 at 20-second intervals)-
induced LTP in the hippocampal CA1 region. In the control
group (n = 15 from 10 rats), baseline fEPSPs (50% of maximal
stimuli with 0.03 Hz) were recorded for 20 min. Tetanic stimuli
then were subsequently delivered only in recordings showing less
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Figure 1 Rotenone suppressed basal synaptic transmission in
concentration- and time-dependent manners. Basic field excitatory postsy-
naptic potentials (fEPSPs) were recorded from the hippocampal CA1 region
following repetitive stimulation (100 μs, 0.03 Hz for 60 min) of Schaffer
collaterals. Stimulation intensity was set to that which induced 50% of the
maximal response. Representative typical traces evoked by single stimula-
tion in the absence or presence of different concentrations of rotenone are
shown (A–C). Summary of the concentration-dependent inhibition of basal
fEPSPs by rotenone is shown (D). Each symbol represents the average from
6–12 slices (from 4–8 rats), and the vertical bars represent ±SE. ∗∗P < 0.01
when comparing evoked responses under control conditions versus 500 nM
rotenone between 70–80 min (horizontal bar).
than ±10% variation in baseline responses. Thereafter, baseline
stimulus-induced fEPSPs were recorded for another 60 min (Fig-
ure 2A). In the rotenone-treated group (n = 16 from 10 rats),
50 nM rotenone was delivered throughout the whole recording
session (total 80 min, Figure 2B). Results showed that rotenone
impaired HFS-induced LTP (Figure 2C). Statistical analyses re-
vealed that the averaged slopes of fEPSPs were significantly re-
duced at 10–60 min following LTP induction in the rotenone-
treated group compared to the control group (n = 15 from 10 rats,
Figure 2D). These results suggest that although 50 nM rotenone
does not alter basal synaptic transmission, it impairs synaptic plas-
ticity in rat hippocampal slices.
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Figure 2 The effects of 50 nM rotenone on LTP initiation andmaintenance.
Typical high-frequency stimulation (HFS)-induced fEPSPs in control (A) and
rotenone-treated (B) slices. (C) Summary of the effects of 50 nM rotenone
on LTP (n = 16 slices from 10 rats). Compared to responses from control
slices (n = 15 from 10 rats), rotenone impaired HFS-induced LTP (D). ∗∗∗P
< 0.001 when comparing normalized slopes of fEPSPs under control condi-
tions versus LTP induction at 10 and 60 min.
Effects of Ketones on Rotenone-Induced
Impairment of LTP in Hippocampal Slices
Rotenone blocks mitochondrial complex I and consequently
causes oxidation and energy crisis [1, 3]. We hypothesized that
these mechanisms may underlie rotenone’s effects on hippocam-
pal synaptic functions. To test this, we co-incubated hippocampal
slices with ketones (1 mM lithium acetoacetate plus 1 mM DL-β-
hydroxybutyric acid sodium salt) and rotenone (50 nM) together
for the recording period (total of 80 min). As shown in Figure 3,
co-treatment with ketones plus rotenone (n = 7 from 5 rats) sig-
nificantly prevented rotenone-induced impairment of LTP (n = 6
from 4 rats, ∗∗∗P < 0.001, when comparing rotenone plus ketones
verses rotenone alone at 60 min of LTP). However, ketones alone
(i.e., without co-application of rotenone) did not alter synaptic
plasticity (n = 7 from 4 rats). These results suggest that ketones
significantly prevent acute exposure of rotenone-induced impair-
ment of hippocampal synaptic plasticity, which is likely mediated
via dysfunction of mitochondrial complex I.
Effects of Rotenone and Ketones on Complex
I-Driven Mitochondrial Respiration
Micromolar concentrations of rotenone have previously been
shown to inhibit mitochondrial complex I [17]. Incubation of iso-
lated mitochondria with 50 nM rotenone for 10 min partially de-
creased oxygen consumption– a direct measure of mitochondrial
respiration– in the presence of the complex I activators glutamate
Figure 3 The effects of ketones on rotenone-induced LTP impairment. This
figure represents high frequency stimulation (HFS)-induced LTP under the
following conditions: (1) 50 nM rotenone (RTN) plus ketones (red symbols,
n=7 from5 rats; 1mM lithiumacetoacetate plus 1mMDL-β-hydroxybutyric
acid sodium salt dissolved in incubation solution); (2) ketones alone (black
symbols,n=7from4rats),and (3) rotenonealone (greensymbols,n=6from
4 rats). These data showed that ketones significantly prevented rotenone-
induced LTP impairment.
and malate (combined with ADP) whereas 500 nM rotenone com-
pletely eliminated oxygen consumption (Figure 4A). In contrast,
preincubation of mitochondria with ketones (1 mM lithium ace-
toacetate plus 1 mM DL-β–hydroxybutyrate acid sodium salt) for
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Figure 4 The effects of rotenone and ketones on complex I-driven mi-
tochondrial respiration. (A) The amount of oxygen consumed by isolated
mitochondria was estimated using the Oxygen Biosensory System (BD Bio-
sciences, San Jose, CA, USA) in the presence of rotenone alone or in combi-
nation with ketones (1 mM acetoacetate plus 1 mM DL-β-hydroxybutyrate).
Complex I was activated with 10 mM glutamate, 10 mM malate and 1 mM
ADP. Oxygen consumption was clearly decreased by 50 nM rotenone
(green), and 500 nM rotenone completely blocked mitochondrial respira-
tion (cyan). In contrast, ketones enhanced complex I-driven mitochondrial
respiration andprevented the inhibitory effects of rotenone. Thedifferences
between the rotenone and rotenone plus ketones groups were statistically
significant (n = 5 animals in each experimental group; ANOVA, P < 0.05).
(B) Ketones did not affect mitochondrial respiration driven by the complex
II substrate succinate (10 mM) in the presence of ADP (1 mM) and rotenone
(1 μM).
10 min enhanced complex I-driven mitochondrial respiration and
prevented the inhibitory effects of rotenone. The differences were
statistically significant (n = 5 animals in each experimental group;
ANOVA, P < 0.05). However, ketones did not affect mitochondrial
respiration driven by the complex II substrate succinate (10 mM)
in the presence of 1 mM ADP and 1 μM rotenone (n = 4 animals;
Figure 4B).
Discussion
The main findings of this study are that acute exposure to
rotenone at low nanomolar concentrations (50 nM) did not af-
fect basal synaptic transmission but significantly impaired LTP in
hippocampal slices. Rotenone toxicity was prevented by enhanc-
ing complex I activity with ketones. Direct measurement of mi-
tochondrial function showed that 50 nM rotenone partially im-
paired oxygen consumption. Our findings suggest that complex I
is likely a sensitive target for hippocampal synaptic plasticity and
might potentially represent a therapeutic target for treatment of
cognitive deficits in patients with PD and possibly other disorders
characterized by hippocampal damage or cognitive decline such as
Alzheimer’s disease.
Rotenone causes highly-selective degeneration of nigrostriatal
neurons and can reproduce many features of PD [18]. Previous
studies have suggested that the hippocampus is much less sen-
sitive than the striatum to complex I inhibition by rotenone [10],
but growing evidence supports our conclusion that rotenone, even
at low concentrations, exerts significant toxicity within the hip-
pocampus. For instance, studies have shown that brief exposure
(1 h) of cultured hippocampal slices to 1–2 μM rotenone induced
CA1 neuron death [8], and chronic exposure (24 h) of cultured
hippocampal slices to 200–300 nM rotenone significantly wors-
ened cellular degeneration [9]. In addition, a recent report has
shown that acute exposure of rat hippocampal slices to 0.1–1 μM
rotenone for 30 min dramatically reduced the amplitude of evoked
population spikes [11]. Collectively, these reports suggest that in-
hibition of mitochondrial respiratory chain complex I can produce
cellular and synaptic changes within the hippocampus.
In the present study, we examined the acute effects of 50 nM
rotenone, a concentration lower than that described in previous
reports but sufficient to significantly decrease complex I activity.
We found that although 50 nM rotenone did not acutely alter
the slope of evoked baseline fEPSPs, it significantly increased both
neuronal excitability and short-term synaptic plasticity but inhib-
ited CA3-CA1 LTP maintenance. Pretreatment with the ketones
acetoacetate and DL-β-hydroxybutyrate– a combination that en-
hanced complex I-driven mitochondrial respiration– prevented
rotenone toxicity. Our data, therefore, suggest that synaptic plas-
ticity is more susceptible to acute mitochondrial dysfunction than
basal synaptic transmission.
Rotenone-induced inhibition of mitochondrial complex I has
two potential consequences: (1) increased production of reactive
oxygen species (ROS) and (2) ATP depletion. Ketones have consis-
tently been shown to prevent oxidative stress and energy failure
[19, 20]. In support of the oxidative stress hypothesis, previous
studies have shown that the oxidant compound hydrogen perox-
ide (H2O2) impairs hippocampal LTP [21, 22] possibly by activat-
ing protein phosphatases 2A or 2B [23]. In the present study, we
found that ketones significantly prevented rotenone-induced LTP
impairment. We also showed that ketones significantly enhanced
oxygen consumption in hippocampal mitochondrial preparations.
Taken together, these results are consistent with previous findings
that ketones prevent oxidative stress and energy failure [19, 20],
which may underlie the protective effect of ketones found in the
present study.
Although PD is characterized by movement disorders in later
stages of the disease, it is now appreciated that there also may be
cognitive impairment, including dementia and behavioral changes
[24–26]. Dementia in patients with PD is consequential and has
been associated with reduced quality of life, shortened survival
and increased caregiver distress. Thus far, there has been consid-
erable progress in regards to defining the scope of cognitive im-
pairment in PD both in terms of epidemiology and risk profiles for
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those most at risk for its development. Investigators, using multi-
ple approaches, including neuropsychology, imaging and pathol-
ogy, suggest there exists a common denominator referable to early
dopamine deficiency but highlight an increasingly important focus
on nondopaminergic pathway involvement [25]. Unfortunately,
the mechanisms of cognitive deficits in PD animal models and pa-
tients have not been well-elucidated. The hippocampus is a key
brain structure for several forms of learning and memory. It is
well-known that the hippocampus is highly sensitive to oxidative
stress, which makes hippocampal synaptic transmission highly de-
pendent on mitochondrial products such as ATP and ROS [27].
Therefore, it is reasonable that changes in hippocampal synaptic
integrity under such pathological conditions would be responsible
for the observed cognitive deficits in PD. In the present study, we
provide direct evidence that rotenone, even at a low concentra-
tion (e.g., 50 nM) that does not affect basal synaptic transmission,
significantly impairs hippocampal synaptic plasticity, which is an
important factor related to synaptic integrity in vitro and thought to
be critical in processes governing learning and memory. Based on
these findings, we speculate that impairment of hippocampal LTP
by rotenone might serve as an underlying mechanism contribut-
ing to cognitive deficits in PD. In addition, our data also suggest
that antioxidative therapies may serve as useful strategies for the
prevention and/or treatment of cognitive deficits in PD.
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